Metabolic stroke in isolated 3-methylcrotonyl-CoA carboxylase deficiency

C Steen, ER Baumgartner, M Duran, W Lehnert… - European journal of …, 1999 - Springer
C Steen, ER Baumgartner, M Duran, W Lehnert, T Suormala, R Fingerhut, M Stehn…
European journal of pediatrics, 1999Springer
A mildly retarded infant with failure to thrive developed hypoglycaemia, focal seizures,
respiratory failure and hemiparesis during a febrile episode at the age of 16 months. A brain
scan was initially normal and showed hemilateral focal edema and gliosis at later stages. 3-
Methylcrotonyl-CoA carboxylase deficiency was suggested by elevated urinary excretion of
3-hydroxyisovaleric acid and 3-methylcrotonylglycine, and confirmed by enzyme assays.
The patient was treated with protein restriction and carnitine and remained stable during the …
Abstract
A mildly retarded infant with failure to thrive developed hypoglycaemia, focal seizures, respiratory failure and hemiparesis during a febrile episode at the age of 16 months. A brain scan was initially normal and showed hemilateral focal edema and gliosis at later stages. 3-Methylcrotonyl-CoA carboxylase deficiency was suggested by elevated urinary excretion of 3-hydroxyisovaleric acid and 3-methylcrotonylglycine, and confirmed by enzyme assays. The patient was treated with protein restriction and carnitine and remained stable during the following 5 years. Hemiparesis and some developmental delay persisted.
Conclusion In acute focal brain disease, metabolic disorders must be considered. 3-Methylcrotonyl-CoA carboxylase deficiency adds to the list of possible causes of “metabolic stroke”.
Springer